These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Intensive Hemodialysis and Treatment Complications and Tolerability. Morfin JA; Fluck RJ; Weinhandl ED; Kansal S; McCullough PA; Komenda P Am J Kidney Dis; 2016 Nov; 68(5S1):S43-S50. PubMed ID: 27772642 [TBL] [Abstract][Full Text] [Related]
27. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans. Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157 [TBL] [Abstract][Full Text] [Related]
28. An IgE immediate reaction to thiocolchicoside. Caimmi D; Caviglioli S; Raschetti R; Demoly P Int J Immunopathol Pharmacol; 2012; 25(1):267-8. PubMed ID: 22507339 [TBL] [Abstract][Full Text] [Related]
29. Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease. Ijaz M; Tariq H; Kashif M; Marquez JG Am J Case Rep; 2015 Apr; 16():232-5. PubMed ID: 25895118 [TBL] [Abstract][Full Text] [Related]
30. Effects of thiocolchicoside, a commonly used myorelaxant, on the acoustic reflex. Arslan HH; Cebeci S; Yildizoglu U; Pusat S; Yavuz F J Laryngol Otol; 2017 Jun; 131(6):497-500. PubMed ID: 28249630 [TBL] [Abstract][Full Text] [Related]
31. [Long-term good results of surgical treatment for spontaneous epi- and subdural hematoma in a female patient on maintenance hemodialysis]. Sułowicz W; Kraśniak A; Gościński I; Cichoński J; Moskała M; Chmiel G; Janusz-Grzybowska E Przegl Lek; 2000; 57(12):764-5. PubMed ID: 11398605 [TBL] [Abstract][Full Text] [Related]
32. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study. Ketenci A; Basat H; Esmaeilzadeh S Agri; 2009 Jul; 21(3):95-103. PubMed ID: 19780000 [TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790 [TBL] [Abstract][Full Text] [Related]
34. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Chang CH; Yang CM; Yang AH Cancer; 2007 Apr; 109(8):1487-92. PubMed ID: 17330839 [TBL] [Abstract][Full Text] [Related]
35. Seizures in dialysis patients treated with recombinant erythropoietin. Beccari M; Romagnoni M; Sorgato G Nephrol Dial Transplant; 1995; 10(3):423-4. PubMed ID: 7792048 [No Abstract] [Full Text] [Related]
36. Warning against unexpected medication in haemodialysis. Quiñones Ortiz L; Suárez Laurés A; Pobes Martínez A; de la Torre M; Torres Lacalle A; Forascepi Roza R Nefrologia; 2011; 31(5):611-2. PubMed ID: 21959734 [No Abstract] [Full Text] [Related]
38. [Renal replacement therapy by hemodialysis: an overview]. Jacobs C Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513 [TBL] [Abstract][Full Text] [Related]
39. Intensive Hemodialysis and Potential Risks With Increasing Treatment. Kraus MA; Kansal S; Copland M; Komenda P; Weinhandl ED; Bakris GL; Chan CT; Fluck RJ; Burkart JM Am J Kidney Dis; 2016 Nov; 68(5S1):S51-S58. PubMed ID: 27772644 [TBL] [Abstract][Full Text] [Related]
40. [Myoneuropathy in patients with chronic renal failure treated with hemodialysis (HD) and intermittent peritoneal dialysis (IPD). I. Evaluation of myoelectric activity of selected skeletal muscles in patients with chronic renal failure treated with hemodialysis and intermittent peritoneal dialysis]. Wanic-Kossowska M; Koczocik-Przedpelska J Pol Arch Med Wewn; 1996 Mar; 95(3):229-36. PubMed ID: 8755853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]